Mr. Steve Loutskou reports

NOVA MENTIS LIFE SCIENCES CORP. ANNOUNCES SHARE CONSOLIDATION, NAME CHANGE AND DEBT SETTLEMENT

Nova Mentis Life Science Corp. plans to consolidate all of the company's issued and outstanding common shares on the basis of five preconsolidated shares for every one postconsolidated share.

The company currently has 148,318,660 shares issued and outstanding. Upon completion of the consolidation, the company will have 29,663,732 shares issued and outstanding. Outstanding convertible securities will be adjusted by the consolidation ratio and the respective exercise prices be adjusted accordingly. Further, in connection with the consolidation, the company intends to change its name to Restart Life Sciences Corp., with a corresponding symbol change, which is yet to be determined.

The company will issue a further news release announcing the effective date in which the company will commence trading under the new name and symbol on a postconsolidated basis.

Further, the company announces that it proposes to enter into debt settlement agreements with certain creditors to settle an aggregate of $318,008.48 in debt. In settlement of the debt, the company proposes to issue, on a postconsolidated basis, 6,360,169 shares at a deemed price of five cents per share. All securities issued in connection with the debt settlement are subject to a statutory hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation.

About Nova Mentis Life Science Corp.

Nova Mentis Life Science is a Canadian-based life sciences company listed on the Canadian Securities Exchange.

We seek Safe Harbor.